Lyell Immunopharma has a total of 298 patents globally, out of which 18 have been granted. Of these 298 patents, more than 75% patents are active. Japan is where Lyell Immunopharma has filed the maximum number of patents, followed by United States of America and China. Parallelly, USA seems to be the main focused R&D centre and also is the origin country of Lyell Immunopharma.
Lyell Immunopharma founded in 2018, is a clinical-stage biotechnology company developing next-generation CAR T-cell therapies for solid tumors and blood cancers. Its therapies use novel technology to create T cells that resist exhaustion and maintain stemness, enabling durable tumor-killing activity and long-lasting clinical response. With a fully integrated model, Lyell drives innovation from discovery to clinical evaluation.
Do read about some of the most popular patents of Lyell Immunopharma which have been covered by us in this article and also you can find Lyell Immunopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Lyell Immunopharma patent portfolio.
How many patents does Lyell Immunopharma have?
Lyell Immunopharma has a total of 298 patents globally. These patents belong to 38 unique patent families. Out of 298 patents, 223 patents are active.
How Many Patents did Lyell Immunopharma File Every Year?

Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Lyell Immunopharma Applications Filed | Lyell Immunopharma Patents Granted |
| 2025 | 1 | 2 |
| 2024 | 18 | 3 |
| 2023 | 33 | 12 |
| 2022 | 119 | – |
| 2021 | 81 | – |
| 2020 | 4 | 1 |
| 2019 | 13 | – |
| 2018 | 19 | – |
| 2017 | 10 | – |
How many Lyell Immunopharma patents are Alive/Dead?
Worldwide Patents

How Many Patents did Lyell Immunopharma File in Different Countries?

Countries in which Lyell Immunopharma Filed Patents
| Country | Patents |
| Japan | 21 |
| United States of America | 20 |
| China | 20 |
| Australia | 20 |
| Canada | 20 |
| Europe (EPO) | 20 |
| Korea (South) | 19 |
| Singapore | 18 |
| Hong Kong (S.A.R.) | 17 |
| Israel | 14 |
| Taiwan | 11 |
| New Zealand | 11 |
| Mexico | 8 |
| India | 8 |
| Brazil | 8 |
| South Africa | 5 |
| Argentina | 3 |
| Germany | 3 |
| Eurasia | 3 |
| Austria | 2 |
| Denmark | 1 |
| Malta | 1 |
| Portugal | 1 |
| Hungary | 1 |
| Italy | 1 |
| Finland | 1 |
| Poland | 1 |
| Spain | 1 |
| Pakistan | 1 |
| Norway | 1 |
Where are Research Centres of Lyell Immunopharma Patents Located?

10 Best Lyell Immunopharma Patents
WO2019068007A1 is the most popular patent in the Lyell Immunopharma portfolio. It has received 56 citations so far from companies like A2 Biotherapeutics, Senti Biosciences & Pionyr Immunotherapeutics.
Below is the list of 10 most cited patents of Lyell Immunopharma:
| Publication Number | Citation Count |
| WO2019068007A1 | 56 |
| WO2018061012A1 | 35 |
| CN111465693A | 17 |
| US20190248869A1 | 14 |
| US20210230251A1 | 7 |
| WO2023133540A1 | 6 |
| WO2022182915A1 | 6 |
| WO2022256437A1 | 5 |
| WO2022087453A1 | 5 |
| WO2021189008A1 | 5 |
What Percentage of Lyell Immunopharma US Patent Applications were Granted?
Lyell Immunopharma (Excluding its subsidiaries) has filed 15 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 3 have been granted leading to a grant rate of 100.0%.
Below are the key stats of Lyell Immunopharma patent prosecution at the USPTO.

Which Law Firms are managing US Patents for Lyell Immunopharma?
| Law Firm | Total Applications | Success Rate |
| Sterne Kessler Goldstein & Fox Pllc | 14 | 100.00% |
| Steptoe Llp | 1 | 100.00% |
What are Lyell Immunopharma key innovation segments?
What Technologies are Covered by Lyell Immunopharma?

The chart below distributes patents filed by Lyell Immunopharma in different countries on the basis of the technology protected in patents. It also represents the markets where Lyell Immunopharma thinks it’s important to protect particular technological inventions.

R&D Focus: How has Lyell Immunopharma search focus changed over the years?

EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by Lyell Immunopharma?